Treatment Patterns With Long-Term Foslevodopa/Foscarbidopa Use in Parkinson’s Disease
Objective: To assess long-term treatment switch patterns and discontinuation rates in patients (pts) with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa (LDp/CDp) mono- or combination therapy.…Coordinated Reset Vibrotactile Therapy for the Treatment of Bradykinesia in Parkinson’s Disease Patients
Objective: The present research examines a novel non-invasive vibrotactile device for stimulation of fingertips in a pattern that aims to disrupt pathological physiological beta-band oscillations…AccessPD Registry Update: Accelerating Parkinson’s Disease Research Through Integrated Digital Solutions
Objective: To update on AccessPD's progress, emphasising the growth in patient recruitment, data integration, and the preliminary analysis aimed at advancing Parkinson's disease (PD) research.…Clinical correlates of apathy in Parkinson´s disease
Objective: To investigate the demographic and clinical correlates of apathy in a group of patients from a Movement Disorders clinic in Latin America. Background: Apathy…Validation of PD Ascertainment in the VA Electronic Medical Record (EMR)
Objective: To determine the validity of PD diagnostic codes in a large national electronic medical database and develop recommendations for maximizing ascertainment accuracy. Background: EMR-based…Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease
Objective: To compare the gastrointestinal dysfunction in patients with early-onset Parkinson’s disease (EOPD) and late-onset Parkinson’s disease (LOPD). Background: Gastrointestinal dysfunction is one of the…Centralizing brain tissue donation for a large multi-site Parkinson’s disease (PD) study
Objective: Brain tissue analysis is an invaluable resource to better understand PD progression, but there is limited access to this resource and swift postmortem collection…‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy
Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…Transforming Parkinson’s Care in Africa: Establishing the First Ever Support Group for People With Parkinson’s Disease and Their Caregivers in Tanzania.
Objective: To establish a support group for people with Parkinson's disease (PwP) and caregivers in Tanzania as part of the Transforming Parkinson’s Care in Africa…PD in Tanzania: representative in city dwellers, absent in nomadic tribespeople?
Objective: To investigate the aetiology of PD demographically in an under researched region. Background: PD monogenic and susceptibility risk factors explain little to none of…
- « Previous Page
- 1
- …
- 250
- 251
- 252
- 253
- 254
- …
- 1734
- Next Page »
